Tonix Pharmaceuticals Holding Corp. (TNXP)

Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD).
For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

Tonix Pharmaceuticals is also enrolling participants in a Phase 3 trial for fibromyalgia.
For more information, please visit www.thereliefstudy.com or www.clinicaltrials.gov (NCT04172831).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
11/20/19 8-K Current report filing
Related Documents
5
11/18/19 424B4 Prospectus filed pursuant to Rule 424(b)(4) 41
11/15/19 8-K Current report filing
Related Documents
59
11/14/19 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 2
11/14/19 EFFECT Notice of Effectiveness 1
11/14/19 S-1/A General form of registration statement for all companies including face-amount certificate companies 51
11/14/19 8-K Current report filing 3
11/14/19 S-1/A General form of registration statement for all companies including face-amount certificate companies
Related Documents
190
11/08/19 FWP Filing under Securities Act Rules 163/433 of free writing prospectuses 26
11/08/19 8-K Current report filing
Related Documents
33
RSS